Immunic
IMUX
IMUX
82 hedge funds and large institutions have $198M invested in Immunic in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 20 increasing their positions, 29 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
19% more funds holding
Funds holding: 69 → 82 (+13)
10.86% more ownership
Funds ownership: 52.23% → 63.08% (+11%)
31% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 29
Holders
82
Holding in Top 10
3
Calls
$12.7M
Puts
$8.88M
Top Buyers
| 1 | +$11.3M | |
| 2 | +$11.2M | |
| 3 | +$10.1M | |
| 4 |
PVI
Pura Vida Investments
New York
|
+$7.72M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$3.76M |
Top Sellers
| 1 | -$1.63M | |
| 2 | -$1.58M | |
| 3 | -$942K | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$678K |
| 5 |
Two Sigma Investments
New York
|
-$613K |